Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?
Therapies Monday, March 11th, 2013Cardiovascular Research: March 1, 2013
Atrial fibrillation (AF) is the most common arrhythmia and one of the most vexing cardiovascular conditions for patients and the physicians who care for them. AF is a primary cause of cardioembolic stroke and may account for more than 20% of all stroke cases in older individuals.1 While AF can easily be diagnosed by electrocardiography, many cases of AF are undetected due to the lack of symptoms. Lifetime risk for developing AF after an age of 40 years is ∼25% for both men and women. The prevalence of AF has been increasing, due to both ageing of the population and an increased prevalence of risk factors such as obesity and sedentary lifestyle. The personal and societal economic consequences of AF are staggering. Read more



























